Download the role of promotion on marketing in turkish drug industry

Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
THE ROLE OF PROMOTION ON MARKETING
IN TURKISH DRUG INDUSTRY
Emrah Bilgener, Erifl Asil, Gülbin Özçelikay*
Ankara University, Faculty of Pharmacy, Department of Pharmacy Management,
06100 Tando¤an, Ankara – TURKEY
Abstract
Marketing has an important role in modern life. Marketing provides economical and social benefits with correleating between producers and consumers.
Promotional activities are necessary for better marketing strategies. Therefore, firms have to give
more importance to promotional activities. Promotional activities are marketing instruments that announced all the knowledges about the products and services to their consumers, for surviving and developing the firms.
Nowadays drug producers are marketing their products all arround the world. But, drugs are not
ordinary products, for this reason more importance must be given to drug marketing and promotion.
The purpose of this study is to determine the role of promotion within the marketing in Turkish
Drug Industry. The material of this study is an uniform questionnaire with 41 questions applied to
about 190-200 medical representatives who work in Çorum, Yozgat, Amasya and Tokat cities for 37
firms which are the members of Federation of Employer’s Organization in Pharmaceutical Industry
and 14 firms which are profited by the services of this federation.
In this study, SPSS program (ver7.5) has been used for evaluation of the data. According to the results, medical represantatives think that the drug sales will increase and wait the data of IMS (Inform
Medicines Statistics) will rise about 60-80%. 90% of the medical represantatives believe that the paramedical activities are effective and 73% of them carry out paramedical studies.
Key Words: Drug Promotion, Promotion, Marketing, Sales Representatives, Turkish Drug Industry.
Türk ‹laç Sanayiinde Pazarlama Üzerinde Tan›t›m›n Rolü
Pazarlama modern yaflant›da önemli bir role sahiptir. Pazarlama üreticiler ve tüketiciler aras›nda
bir iliflki kurarak, ekonomik ve sosyal faydalar sa¤lar. Tan›t›m faaliyetleri daha iyi bir pazarlama
stratejisi için gereklidir. Bu nedenle flirketler daha iyi bir pazarlama stratejisi için tan›t›m faaliyetlerine önem vermelidir. Tan›t›m faaliyetleri, iflletmenin üretti¤i mal ve hizmetleri tüketicilere duyuran,
iflletmenin geliflimini ve yaflamas›n› sa¤layan bir pazarlama arac›d›r
Günümüzde ilaç üreticileri, ürettikleri ürünleri tüm dünyada pazarlamaktad›rlar. Ancak, ilaç herhangi bir ürün olmad›¤› için, pazarlamas›na ve tan›t›m›na dikkat edilmelidir.
Bu çal›flman›n amac›, Türk ‹laç Sanayii’nde pazarlama faaliyetleri aras›nda yer alan ilaç
tan›t›m›n›n sektör üzerindeki etkilerinin incelenmesidir. Çal›flman›n materyalini ‹stanbul ilinde bulunan, ‹laç Endüstrisi ‹flverenler Sendikas› üyesi olan 37 ve sendika hizmetlerinden yararlanan 14 firma
bünyesinde ve Çorum, Yozgat, Amasya, Tokat illerinde çal›flan say›lar› 190-200 olan t›bbi mümessiller
için haz›rlanan 41 soruluk anket formlar› oluflturmaktad›r.
Araflt›rmada verilerin de¤erlendirilmesi için SPSS (ver. 7.5) istatistik paket program›
kullan›lm›flt›r. Araflt›rma sonucunda elde edilen sonuçlara göre, t›bbi mümessiller, tan›t›m ile ilgili
çal›flmalar sonucunda ilaç sat›fllar›n›n artaca¤›n› düflünmektedir ve buna ba¤l› olarak IMS (‹nformational Medicine Statistics) verilerinde % 60-80 oran›nda art›fl olaca¤›n› beklemektedirler. Çal›flmaya
kat›lan t›bbi mümessillerin % 90’› tan›t›mda para-medikal çal›flmalar›n etkinli¤ine inanmakta ve %
73’ü tan›t›mda para-medikal çal›flma yapmaktad›r.
Anahtar sözcükler: ‹laç Tan›t›m›, Tan›t›m, Pazarlama, T›bbi Mümessil, Türk ‹laç Sanayi.
*Corresponding author:
Fax: +90 0312 213 10 81, e-mail: [email protected]
87
E. Bilgener, E. Asil, G. Özçelikay
Introduction
Promotion has more attractive features than advertising and other marketing functions. Promotion when lets uprising sales to good services and products, can not verify
worthless products to live longer (1).
Drug is an important product for human health. Drug producers have an important and
necessary mission for the human health, because they serve new and developed products
for the society.
Today, drug producers market the products which they invent and developed. But more importance has been given to drug marketing, because drug is not an ordinary thing.
Drug promotion is sensed as an important subject all arround the world. In our country, drugs are being marketed and promoted in a way forever years. But as in all sectors, some problems occur about promotion in drug sector. The main problem is the positive or negative effects on sector about the subjective or objective behaving of marketing and promotion strategies which applied by the drug firms.
In Turkey, medical products which wanted to be given inner market are under the
control of Health Ministry by the 1262 numbered law ‘Pharmaceutical and Medicinal
Drugs Law’ which inured in 1928 and regulated in 1948. And related to this ‘The Regulation
of
Medical Factory made
Pharmaceutics Promotion’ was published in
07.09.1990 number 20628 in The Official Gazette (2). The aim of this regulation is to set
the rules of chemical, vegetal and biological originated Pharmaceutical and Medicinal
Drugs Promotions which are used in order to save human beings from disease, diagnosis, treatment or changing a function of a part of the body, and according to this to able
the rational usage of this Pharmaceutics (3,4).
Drug promotions are the convincing activities for drugs, to be written in recipe, assurance, sales and/or reason for usage, by producers, importers and distributors (5).
In this study, the aim is defined ‘How are the Promotion activities acted and how do
they effect the drug sales or in what constant they are effective on marketing.’
88
Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
Experimental
Materials of this study are formed by the questionnaire with 41 questions and applied to representatives, working in Çorum, Yozgat, Amasya, Tokat regions, workers of 51
different firms in pharmaceutical ›ndustry. 37 of which are the members of Pharmaceutical Manufacturers’ Association and 14 of which uses the services provided by the Association.
The questionnaire forms were applied to 200 representatives by face to face and by
mail. 135 questionnaire forms were taken under consideration. Which is the 67.5% of the
region. This number is considered enough statistically because of being bigger than 30
% (6).
In this study, SPSS program (ver7.5) has been used for evaluation of the data.
Results
The participant representatives ages were; 23-25 (3%), 26-28 (54%), 29-31 (33%) and
older than 32 (9%). 24% of them had a high school degree and 76% of them had a university degree. 64% of them worked in another sector before, 53 % of them work in the
same firms mostly for 2 years.
89
E. Bilgener, E. Asil, G. Özçelikay
Graphic 1. Distribution of representatives who informed about drug promotion.
Graphic 2. Thoughts of representatives about the liability of information given to them
about promotion.
90
Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
Graphic 3. The satisfaction ratio of representatives from the promotion strategies of
their firm
Graphic 4. The thoughts of representatives about the promotion strategy of their firm
1st line
2nd line
: Disparity of Central Strategies
3rd line
4th line
: Insufficient Education about Product
5th line
6th line
: Insufficient Reminding Material
: Insufficient Marketing Power
: Insufficient Budget
: Insufficient Reminding Material and Sample
91
E. Bilgener, E. Asil, G. Özçelikay
Graphic 5. Distribution of the people who gives the first information to representati
ves about the promotion.
Graphic 6. Distribution of the basic subjects during promotion which representatives
take care
92
1st line
2nd line
: Effect Mechanism (Effect, side effect etc.)
3rd line
4th line
: Comparison with rival products and differentiation
5th line
: Performing the promotion within the ethic criteria
: Benefits to patient and doctor. (Most effective, easy usage)
: Suitable Price (Prompt and suitability of price)
Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
Graphic 7. General evaluation of the information given by representatives during
promotion
1st line : Effect Mechanism (Effect, side effect etc.)
2nd line : Benefits to patient and doctor. (Most effective, Easy usage)
3rd line : Comparison with rival products and differentiation
4th line : Suitable Price (Prompt and Suitability of Price)
5th line : Reminding Materials
Graphic 8. Distribution of the thoughts of representatives about the promotion products
as a reminding material
93
E. Bilgener, E. Asil, G. Özçelikay
Graphic 9. Distribution of the situation whatever the representatives ideas are taken
under care while determining the promotion strategies.
Graphic 10. Distribution of the situation whatever the representatives ideas are taken
under care while determining the promotion materials.
94
Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
Graphic 11. Distribution of the firms whatever representatives have a slogan about
promotion.
Graphic 12. Distribution of whether the representatives have the effective usage of the
visual materials (brochure, poster, card etc.) or not during promotion
95
E. Bilgener, E. Asil, G. Özçelikay
Graphic 13. Distribution of representatives thoughts about detailing during promotion.
Graphic 14. Distribution of the Analyze ability of representatives for the doctor’s
prescription tendency.
96
Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
Graphic 15. Distribution of representatives technique for analyzing the doctor’s
prescription tendency.
Graphic 16. Distribution of representatives thoughts about doctor’s prescription
tendency
1st line : Good bilateral relations
2nd line : Likes the drug
5th line
6th line
: Activity of drug
3rd line : Taking the paramedical
4th line : Habits
7th line
: No equivalent drug work
: Frequently visit
97
E. Bilgener, E. Asil, G. Özçelikay
Graphic 17. Distribution of representatives thoughts about sales increase of product
which is promoted intensively
Graphic 18. Distribution of the representatives thoughts about the criteria of failure
against dense promotion
1st line : Inactivity of drug
2nd line : Rival activities
3rd line : Wrong targeting
5th line : Represent factor
6th line : Doctor’s habit
7th line : Insufficient promotion
4th line : Insufficient paramedical work
8th line : Maturity of drug
98
Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
Graphic 19. Distribution of situation if representatives try to persuade doctors or
pharmacists who have bad thoughts about products.
Graphic 20. Distribution of the situation if the representatives take feed back about the
promotion they do.
99
E. Bilgener, E. Asil, G. Özçelikay
Discussion and Conclusion
94% of the medical representatives who replied the questionnaire, were taken information about promotion, 6% of them were not taken any information. However 68% of
them indicated that this was an insafficient information (Graphic 1-2). This shows that
most of the education departments of drug firms are insufficient or have wrong strategies.
68% of medical representatives indicated that the promotion strategy of their firms are
insufficient (Graphic 3). When the causes of insufficiency was analyzed, it was seen that
the ‘regional disparity of central strategies’ in the first line. ‘Insufficient marketing power’ in the 2nd line. ‘Insufficient product education’ in the 3rd line. ‘Insufficient budget’
in the 4th line, ‘insufficient reminding material’ (promotion) in the 5th line and ‘insufficient promotional material and sample’ in the 6th line (Graphic 4).
89% of representatives indicated that, first information about product was given by
product managers or education department (Graphic 5). Almost 90% of firms have product managers or education department and the education given by them is considered
insufficient by representatives shows that the liability of these must be examined. Also
the insufficient period and contents of education programs must be revised and the education period is short. The firms declared that they have a training program with less than
3 months for inexperienced representatives (7). It is thought provoking that how the inexperienced representatives will apply their work with less than 3 months training .
When the evaluation of basic subjects that representatives take care during promotion was analyzed, it was seen that the ‘effect mechanism’ is in 1st line, ‘benefits of
patients and doctors’ in 2nd line, ‘comparison with rival and occurring differentiation’ in
3rd line, ‘suitable prices’ in 4th line and ‘acting the principle of ethics promotion’ was in
5th line (Graphic 6).
When the information that were given by representatives was analyzed, it was seen
that; ‘benefits of patient and doctor’ is in 1st line, ‘effect mechanism’ in 2nd line, ‘comparison with rival products and occurring differentiation’ in 3rd line, ‘suitable prices’ in
4th line and ‘reminding material’ was in 5th line (Graphic 7).
100
Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
77% of representatives thought that promotional products are reminding materials,
9% of them have disagreement about that, and 14% of them thought that this was often
happening (Graphic 8). According to this data it can be concluded that promotional products were used suitable for their usage aims.
Most of the representatives (77%) declared that their opinions were not taken while
the promotion strategies were built up by their firms (Graphic 9). This evaluation is the
evidential data for considering the central strategies were insufficient.
51% of representatives declared that their ideas were not considered as useful while
selecting the reminding materials by firms. 18% of representatives ideas were taken usually and 31% of representatives ideas were taken sometimes (Graphic 10).
92% of representatives said that they had slogans for promotion (Graphic 11).
84% of representatives declared that they use the visual materials effectively during
promotion (Graphic 12).
Thoughts of representatives about detailing; 30% were positive, 39% were negative
and %31 were sometimes positive (Graphic 13).
71% of representatives could analyze the prescription tendency of doctors, 8% of
them could not, and 21% of them were sometimes able to analyze it (Graphic 14).
100% of representatives analyze this tendency by following the IMS (Informational
Medical Statistics) data, 72% of them by analyzing and controlling the prescription, 65%
of them by taking order from pharmacies and 27 % of them by using other methods
(Graphic 15).
If representatives thoughts were analyzed about the doctors prescription tendencies,
it was seen that, ‘bilateral relations’ take part in 1st line with 28%, ‘likes the drug’ in 2nd
line with 26%, ‘taking paramedical work’ in 3rd line with 26%, ‘habits’ in 4th line with
29%, ‘the activity of drug’ is in 5th line with 30%, ‘frequent visits’ in 6th line with 29%,
and ‘no equivalent drug’ take part in 7th line with the highest ratio (46%) (Graphic 16).
Most of the representatives thought that the IMS data could be changed with promotional activities. Most of them declared that this difference may be in 41-80% value
(Graphic 17).
When the information of representatives thoughts about the criteria of failure against
dense promotion were analyzed, it was seen that ‘inactivity of drug’ took part in 1st line
with 28%, ‘rival activities’ in 2nd line with 22%, ‘wrong targeting’ in 3rd line with 26%,
‘insufficient paramedical work’ in 4th line with 23%, ‘representative factor’ in 5th line
101
E. Bilgener, E. Asil, G. Özçelikay
with 23%, ‘doctors’ habit’ in 6th line with 27%, ‘insufficient promotion’ in 7th line with
29%, the ‘maturity of drug’ was in 8th line with 27% (Graphic 18).
98% of representatives tried to persuade doctors and pharmacists who have negative
opinions during promotion (Graphic 19).
76% of representatives took feed back, 3% of them did not and 21% of them sometimes took feedback (Graphic 20).
As a conclusion, we can summarize the results which are given below, under the light
of this study:
• Drug firms inform representatives about promotion.
• However according to the representatives the education is insufficient.
• 68% of representatives think their firms’ promotion strategies are insufficient.
• Drug firms have department of education or a responsible department for education.
But these departments are not sufficient.
• There are some differences in application and basic subjects of promotion for rep-
resentatives.
• The promotion strategies do not satisfy the representatives.
• Representatives believe that promotion products are reminding materials.
• Firms have slogans for products which are in their wallet.
• Representatives believe that visual materials must be used effectively during promotion and they can use them effectively during promotion.
• Representatives do not believe that detailing is important.
• They can analyze the doctors’ tendency.
• They follow these tendencies by following IMS data, prescription control and taking order from pharmacies.
• They think doctors’ prescription tendencies have different reason.
• They think the values of IMS can be changed by promotional works.
• According to the representatives, in spite of intense promotional activities the failure shows difference. Representatives try to persuade the doctors who have negative
opinions about the drugs during promotion. They use different methods for this. But the
liability and ethics of these methods must be discussed.
• Representatives take feed-back about promotion.
102
Turkish J. Pharm. Sci. 1 (2), 87-104, 2004
References
1. Smith, M., Pharmaceutical Marketing, Strategy and Cases. Pharmaceutical Press,
New York, 1991.
2. Özçelikay, G., ‹laçta Reklam. T›bbi Etik Dergisi, Say› 6, 33-39, 1998.
3. Akal›n, K. ‹laç ve Eczac›l›k; Uluslararas› Antlaflmalar, Kanunlar, Yönetmelik-ler,
Genelgeler, Sa¤l›k Bakanl›¤› Yay›nlar›, Ankara, 1991.
4. Resmi Gazete , say›. 24630, 04/01/, 2002.
5. Ayl›k Rapor ‹E‹S, ‹stanbul, 1993.
6. Karasar, N. Bilimsel Araflt›rma Yöntemi, 3A Araflt›rma E¤itim Dan›flmanl›k Ltd.,
‹stanbul, 1993.
7. Özler, D. Türk ‹laç Endüstrisinde Sat›fl Gücü E¤itimi, Yüksek Lisans Tezi, Ankara
Üniversitesi Sa¤l›k Bilimleri Enstitüsü, Ankara, 2002.
received: 16.04.2004
accepted: 02.07.2004
103